Your browser doesn't support javascript.
loading
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
Guillet, Benoit; Yan, Songkai; Hooper, Becky; Drelich, Douglass; Steenkamp, Jason; Tomic, Radovan; Mancuso, Maria Elisa.
Afiliação
  • Guillet B; Hemophilia Treatment Center of Rennes-Bretagne, University Hospital Center (CHU) Rennes, Rennes, France.
  • Yan S; CSL Behring, 1020 1st Avenue, King of Prussia, PA, 19406, USA. Songkai.Yan@cslbehring.com.
  • Hooper B; EVERSANA, Burlington, Canada.
  • Drelich D; CSL Behring, 1020 1st Avenue, King of Prussia, PA, 19406, USA.
  • Steenkamp J; EVERSANA, Burlington, Canada.
  • Tomic R; CSL Behring, Milan, Italy.
  • Mancuso ME; IRCCS Humanitas Research Hospital and Humanitas University, Milan, Italy.
Adv Ther ; 41(2): 649-658, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38070040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator IX / Hemofilia B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator IX / Hemofilia B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article